trial · primary record
Biospecimen Collection
Lung Non-Small Cell Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2033-12-02 |
| Primary endpoint | Major pathologic response (MPR) rate (Group A) |
| Registry ID | NCT06918132 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:13.731Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06918132
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biospecimen Collection · compound